NeuroScience Pharmaceuticals, Synereca Pharmaceuticals To Participate At CED`s October STREAK Seminar

Oct. 8 Seminar Offers Professional Mentoring For Local Life Sciences Startup
Companies
RESEARCH TRIANGLE PARK, N.C.--(Business Wire)--
CED, formerly the Council for Entrepreneurial Development (www.cednc.org), a
private, nonprofit organization that promotes entrepreneurial efforts in the
Triangle region of North Carolina, has announced that it will host the next
installment of its popular STREAK program, to be held Thursday, Oct. 8 from 3
p.m. to 5 p.m. STREAK is designed to assist early-stage, high-growth life
sciences and technology companies in preparing for and reaching fundraising
goals through the critique of pitch presentations by a seasoned panel of
investors, entrepreneurs and marketing experts.

Presenting companies include NeuroScience Pharmaceuticals
(www.neurosciencepharma.com), a Research Triangle Park-based clinical stage
company, and Chapel Hill-based drug developer Synereca Pharmaceuticals.
Panelists include Barry Brand, CEO and director of CeNeRx BioPharma, Inc.;
investor and entrepreneur Bruce Boehm; Turner Jenkins, investment analyst at
Pappas Ventures; Helga Leftwich of Hutchison Law Group; Tim Trost, vice
president and CFO of Argos Therapeutics, Inc.

STREAK is a closed-door session opportunity that is only available to CED
members and takes place on the second Thursday afternoon of each month. Of the
12 companies selected to present before the panels, CED will select the most
notable presenters to showcase at a January event. For details on entry criteria
and the application process, CED members should e-mail their business plan and
other relevant information to program coordinators Bob Pickens at
bpickens@cednc.org or Dhruv Patel at dpatel@cednc.org.

QUOTES:

"NeuroScience Pharmaceuticals and Synereca Pharmaceuticals both represent the
kind of exciting startup companies flourishing in our local biosciences sector,"
said CED president Joan Siefert Rose. "CED is delighted to share with them the
opportunity to meet with the Triangle`s thought leaders in entrepreneurship."

NEW MEDIA CONTENT:

Council for Entrepreneurial Development blog

http://cednc.wordpress.com

Council for Entrepreneurial Development Twitter page

http://twitter.com/CEDNC

DETAILS:

- NeuroScience Pharmaceuticals is a clinical stage company dedicated to the
development of a pipeline of neurosteroid drugs for the treatment of brain
disorders, including therapeutic indications for schizophrenia, post traumatic
stress disorder (PTSD), traumatic brain injury (TBI), depression, Alzheimer's
and addiction.

- Synereca Pharmaceuticals was created to address the growing problem of
bacterial resistance to current antibiotics by developing orally active drugs
that restore or increase the effectiveness of existing antibiotics. The
company`s initial program focuses on inhibiting RecA, a key enzyme in bacterial
DNA repair as well as in the development and transmission of antibiotic
resistance. Prototype RecA inhibitors potentiate the killing of a wide variety
of pathogenic bacteria by a broad range of bactericidal antibiotics.

- One of CED`s most popular and valuable offerings, STREAK provides members the
opportunity to submit their business plan and investor pitch for consideration
to present before a custom-built expert panel. The panelists are hand-picked to
address the specific needs of each company by providing feedback on strategy,
business advice, funding options and additional relevant contacts. STREAK is
sponsored by Hutchison Law Group and Hughes Pittman & Gupton, LLP.

ABOUT CED:

CED (formerly The Council for Entrepreneurial Development) is a private,
nonprofit organization founded in 1984 to identify, enable and promote
high-growth, high-impact companies and accelerate the region`s entrepreneurial
culture. Headquartered in the Research Triangle Park, CED is the oldest and
largest entrepreneurial support organization in the nation with more than 5,500
active members. CED provides know-how, networking, mentoring and capital
formation resources to new and existing high-growth entrepreneurs through annual
conferences, programs and web-based resources. CED has helped entrepreneurs,
investors, service partners, researchers and public policy makers in diverse
emerging industries and at all stages of development - from high-tech,
production-based organizations to service companies, from one-person start-ups
to 1000-person businesses. Visit www.cednc.org for more information.

MMI Public Relations
Jake Potter or Patty Briguglio, 919-233-6600;
jake@mmipublicrelations.com or patty@mmipublicrelations.com
http://twitter.com/MMIPR; www.mmipublicrelations.com

Copyright Business Wire 2009